- Home
- BCAB vs SHFS Comparison
BCAB vs SHFS Comparison
Compare BCAB & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- SHFS
- Stock Information
- Founded
- BCAB 2007
- SHFS 2015
- Country
- BCAB United States
- SHFS United States
- Employees
- BCAB N/A
- SHFS N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- SHFS Finance: Consumer Services
- Sector
- BCAB Health Care
- SHFS Finance
- Exchange
- BCAB Nasdaq
- SHFS Nasdaq
- Market Cap
- BCAB 22.3M
- SHFS 20.8M
- IPO Year
- BCAB 2020
- SHFS N/A
- Fundamental
- Price
- BCAB $0.41
- SHFS $2.78
- Analyst Decision
- BCAB Buy
- SHFS
- Analyst Count
- BCAB 2
- SHFS 0
- Target Price
- BCAB $1.00
- SHFS N/A
- AVG Volume (30 Days)
- BCAB 421.1K
- SHFS 26.5K
- Earning Date
- BCAB 05-06-2025
- SHFS 05-21-2025
- Dividend Yield
- BCAB N/A
- SHFS N/A
- EPS Growth
- BCAB N/A
- SHFS N/A
- EPS
- BCAB N/A
- SHFS N/A
- Revenue
- BCAB $11,000,000.00
- SHFS $13,956,453.00
- Revenue This Year
- BCAB N/A
- SHFS N/A
- Revenue Next Year
- BCAB N/A
- SHFS N/A
- P/E Ratio
- BCAB N/A
- SHFS N/A
- Revenue Growth
- BCAB N/A
- SHFS N/A
- 52 Week Low
- BCAB $0.24
- SHFS $1.84
- 52 Week High
- BCAB $2.53
- SHFS $15.20
- Technical
- Relative Strength Index (RSI)
- BCAB 50.31
- SHFS 50.65
- Support Level
- BCAB $0.37
- SHFS $2.25
- Resistance Level
- BCAB $0.42
- SHFS $2.83
- Average True Range (ATR)
- BCAB 0.04
- SHFS 0.27
- MACD
- BCAB -0.01
- SHFS 0.12
- Stochastic Oscillator
- BCAB 35.88
- SHFS 94.62
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.